Arkolith/Insider Trading/KLRA/Form 4

RTW Investments, LP

10% OwnerKailera Therapeutics, Inc. (KLRA) · full profile →Form 4 · filed Apr 22, 2026
Net Buying
Open-Market Buys
$8.0M
Open-Market Sells
$0
Net Open-Market Flow
$8.0M
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Conversion(C)10.3M——10.3M
Apr 20, 2026Buy(P)500K$16.00$8.0M10.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Conversion(C)8.3M——0
Apr 20, 2026Conversion(C)2.0M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000390) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML